Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma

Published:2022-10 Issue:4 Volume:82 Page:427-439
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Bedke Jens,Rini Brian I.,Plimack Elizabeth R.,Stus Viktor,Gafanov Rustem,Waddell Tom,Nosov Dimitry,Pouliot Frederic,Soulières Denis,Melichar Bohuslav,Vynnychenko Ihor,Azevedo Sergio J.,Borchiellini Delphine,McDermott Raymond S.,Tamada Satoshi,Nguyen Allison Martin,Wan Shuyan,Perini Rodolfo F.,Rhoda Molife L.,Atkins Michael B.,Powles Thomas

Publisher

Elsevier BV

Subject

Urology

Reference22 articles.

5. Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinoma;Cella;Cancer,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting endothelial cell anergy to improve CAR T cell therapy for solid tumors;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Quality of life and patient‐reported toxicities in patients with advanced Merkel cell carcinoma treated with combined nivolumab and ipilimumab with or without stereotactic body radiation therapy;Cancer Medicine;2024-07

3. Excess Weight leads to a better Health-Related Quality of Life in patients with Cancer;2024-05-09

4. Evaluating the clinical benefit of pembrolizumab as a first-line agent in advanced solid tumors: A comprehensive review;Journal of Oncology Pharmacy Practice;2024-05-06

5. Using three-dimensional model-based tumour volume change to predict the symptom improvement in patients with renal cell cancer;3 Biotech;2024-05